Actively Recruiting
Study of WP1066 Combined With Radiation Therapy for Adults With Newly Diagnosed Glioblastoma
Led by Northwestern University · Updated on 2026-07-22
39
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how well WP1066 combined with radiation therapy works for adults newly diagnosed with glioblastoma, a type of brain tumor. This Phase II trial focuses on patients with MGMT-unmethylated glioblastoma, a subtype that is challenging to treat. WP1066 targets the STAT3 pathway, which promotes tumor growth and helps the tumor evade the immune system, while radiation therapy aims to stop tumor growth. The study seeks to understand the impact of this combination on tumor progression and survival. Participants are divided into two groups based on tumor removal status after initial surgery. Those with complete tumor removal receive WP1066 orally for 6 weeks during radiation therapy, followed by twelve 28-day cycles of WP1066. Those without complete tumor removal receive WP1066 for 6 weeks during radiation, may have additional surgery or biopsy if eligible, and then continue WP1066 for twelve 28-day cycles. Throughout the study, participants undergo routine radiation therapy, MRIs, blood sample collections, and possibly surgical procedures. During the trial, participants will have regular MRI scans and blood tests to monitor tumor status and immune response. Researchers will measure progression-free survival, overall survival, tumor response, and safety of WP1066 with radiation. The study also explores changes in the tumor environment and uses advanced imaging analysis. Participants are monitored for up to 36 months, with assessments of disease progression, treatment response, and side effects.
CONDITIONS
Brief Title
WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here